Evidence map›Paper›PMID 42871086›Full record

ArticleFrontiers in immunology2026

X-linked hyper IgM syndrome with a novel CD40-ligand gene mutation suffered from infection of Talaromyces marneffei.

Juan Gu, Aiyan Ren, Jing Kong, Meiying Huang, Huijuan Jin, Chengxin Sun, Shiji Xiao, Enming Zhang, Zuochen Du

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan Gu *Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Aiyan Ren *Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jing Kong *Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Meiying HuangDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Huijuan JinNursing Department, Ordnance Industry Hygiene Research Institute, Xi'an, Shaanxi, China.
Chengxin SunSchool of Pharmacy, Zunyi Medical University, Zunyi, China.
Shiji XiaoSchool of Pharmacy, Zunyi Medical University, Zunyi, China.
Enming ZhangDepartment of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmö, Sweden.
Zuochen DuDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: X-linked Hyper-IgM Syndrome (X-HIGM) is a primary immunodeficiency caused by pathogenic variants in Methods: We report a 4-year-old Chinese girl who developed disseminated Talaromyces marneffei infection and was subsequently diagnosed with X-HIGM. Her clinical history and laboratory findings were reviewed, and a comprehensive immunological evaluation was performed, including flow cytometric analysis. Genetic testing was carried out by next-generation sequencing, and the identified variant was confirmed by Sanger sequencing. The possible effect of the Results: A previously undescribed heterozygous Discussion: We identified a

Indexed as

CD40 LigandHyper-IgM Immunodeficiency Syndrome, Type 1MutationMycosesTalaromycesChild, PreschoolFemaleHumansCD40 LigandCD40Lgene mutationgene sequencingTalaromyces marneffeithe X-linked hyper-IgM

Identifiers

PMID42871086
PMCPMC13658162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.